由于基因页面包含大量信息，因此加载平均需要3-5秒。因此，当您单击基因ID时，请耐心等待加载页面。
| Gene ID | 象征 | Synonyms | Official Full Name | Location | SZ group? | Functional group? |
|---|---|---|---|---|---|---|
| 4791 | NFKB2 | CVID10 |H2TF1 |Lyt-10 |lyt10 |NF-KB2 |P100 |P49/P100 |p52 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 | 10q24 | CV:PGCnp DMG:Nishioka_2013 GO_Annotation Network |
|
| 567 | B2M | IMD43 | beta-2-microglobulin | 15q21.1 | CV:PGCnp PMID:cooccur |
|
| 50615 | IL21R | CD360 |尼尔 | 白介素21受体 | 16p11 | CV:PGCnp DMG:vanEijk_2014 GSMA_IIE |
|
| 58191 | CXCL16 | CXCLG16 | SR-PSOX | SRPSOX | C-X-C motif chemokine ligand 16 | 17p13 | PMID:cooccur | |
| 6355 | CCL8 | HC14 |MCP-2 |MCP2 |Scya10 |Scya8 | C-C基序趋化因子配体8 | 17q11.2 | CV:PGCnp PMID:cooccur |
|
| 6357 | CCL13 | CKb10 | MCP-4 | NCC-1 | NCC1 | SCYA13 | SCYL1 | C-C基序趋化因子配体13 | 17q11.2 | PMID:cooccur | |
| 6354 | CCL7 | FIC | MARC | MCP-3 | MCP3 | NC28 | SCYA6 | SCYA7 | C-C基序趋化因子配体7 | 17Q11.2-Q12 | Network PMID:cooccur |
|
| 6347 | CCL2 | GDCF-2 |HC11 |HSMCR30 |MCAF |MCP-1 |MCP1 |scya2 |SMC-CF | C-C基序趋化因子配体2 | 17Q11.2-Q12 | CV:PGCnp Expression PMID:cooccur |
|
| 6352 | CCL5 | D17S136E | RANTES | SCYA5 | SIS-delta | SISd | TCP228 | eoCP | C-C基序趋化因子配体5 | 17q12 | DMG:vanEijk_2014 PMID:cooccur |
|
| 6346 | CCL1 | I-309 | P500 | SCYA1 | SISe | TCA3 | C-C基序趋化因子配体1 | 17q12 | CV:PGCnp PMID:cooccur |
|
| 6348 | CCL3 | G0S19-1 | LD78ALPHA | MIP-1-alpha | MIP1A | SCYA3 | C-C基序趋化因子配体3 | 17q12 | PMID:cooccur | |
| 718 | C3 | AHUS5 | ARMD9 | ASP | C3a | C3b | CPAMD1 | HEL-S-62p | complement component 3 | 19p13.3-p13.2 | Association CV:PGCnp GO_Annotation GR_Ng GR_WM PMID:cooccur |
|
| 7040 | TGFB1 | CED | DPD1 | LAP | TGFB | TGFbeta | transforming growth factor beta 1 | 19q13.1 | CV:PGCnp GO_Annotation Network PMID:cooccur |
|
| 5971 | RELB | I-REL | IREL | REL-B | v-rel avian reticuloendotheliosis viral oncogene homolog B | 19q13.32 | CV:PGCnp GO_Annotation Network |
|
| 3586 | IL10 | CSIF | GVHDS | IL-10 | IL10A | TGIF | interleukin 10 | 1q31-q32 | Association CV:PGCnp GO_Annotation gr_cor GR_Ng GR_WM PMID:cooccur |
|
| 8809 | IL18R1 | CD218a | CDw218a | IL-1Rrp | IL18RA | IL1RRP | interleukin 18 receptor 1 | 2q12 | Association CV:PGCnp Expression GR_WM GSMA_I PMID:cooccur |
|
| 7850 | IL1R2 | CD121b | CDw121b | IL-1R-2 | IL-1RT-2 | IL-1RT2 | IL1R2c | IL1RB | interleukin 1 receptor type 2 | 2q12 | CV:GWAScat CV：GWASDB CV:PGCnp GSMA_I |
|
| 3552 | IL1A | IL-1A | IL1 | IL1-ALPHA | IL1F1 | interleukin 1 alpha | 2q14 | Association CV:GWAScat CV：GWASDB GR_WM GSMA_I GSMA_IIA PMID:cooccur |
|
| 1230 | CCR1 | CD191 | CKR-1 | CKR1 | CMKBR1 | HM145 | MIP1aR | SCYAR1 | C-C motif chemokine receptor 1 | 3p21 | CV:PGCnp DMG:Wockner_2014 PMID:cooccur |
|
| 1232 | CCR3 | CC-CKR-3 | CD193 | CKR3 | CMKBR3 | C-C基序趋化因子受体3 | 3p21.3 | CV:PGCnp PMID:cooccur |
|
| 1234 | CCR5 | CC-CKR-5 | CCCKR5 | CCR-5 | CD195 | CKR-5 | CKR5 | CMKBR5 | IDDM22 | C-C基序趋化因子受体5（基因/假基因） | 3p21.31 | Network PMID:cooccur |
|
| 942 | CD86 | B7-2 | B7.2 | B70 | CD28LG2 | LAB72 | CD86 molecule | 3q21 | CV:PGCnp PMID:cooccur |
|
| 2919 | CXCL1 | FSP |gro1 |GROA |mgsa |mgsa-a |NAP-3 |scyb1 | C-X-C motif chemokine ligand 1 | 4q21 | CV:PGCnp GO_Annotation PMID:cooccur |
|
| 2920 | CXCL2 | CINC-2a | GRO2 | GROb | MGSA-b | MIP-2a | MIP2 | MIP2A | SCYB2 | C-X-C motif chemokine ligand 2 | 4q21 | CV:PGCnp DMG:Jaffe_2016 PMID:cooccur |
|
| 2921 | CXCL3 | CINC-2b | GRO3 | GROg | MIP-2b | MIP2B | SCYB3 | C-X-C motif chemokine ligand 3 | 4q21 | CV:PGCnp DMG:Jaffe_2016 |
|
| 3627 | CXCL10 | C7 |ifi10 |INP10 |IP-10 |Scyb10 |CRG-2 |GIP-10 |MOB-1 | C-X-C motif chemokine ligand 10 | 4q21 | CV:PGCnp PMID:cooccur |
|
| 4283 | CXCL9 | CMK | Humig | MIG | SCYB9 | crg-10 | C-X-C motif chemokine ligand 9 | 4q21 | PMID:cooccur | |
| 4790 | NFKB1 | CVID12 | EBP-1 | KBF1 | NF-kB1 | NF-kappa-B | NF-kappaB | NFKB-p105 | NFKB-p50 | NFkappaB | p105 | p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 4q24 | CV:GWAScat CV：GWASDB CV:PGCnp Network PMID:cooccur |
Ascano FMRP targets |
| 3593 | IL12B | CLMF | CLMF2 | IL-12B | IMD28 | IMD29 | NKSF | NKSF2 | interleukin 12B | 5q33.3 | Association CV:PGCnp GR_Ng GR_WM GSMA_I GSMA_IIA GSMA_IIE PMID:cooccur |
|
| 3120 | HLA-DQB2 | HLA-DQB1 | HLA-DXB | 主要组织相容性复合体II级DQ beta 2 | 6p21 | CV：GWASDB CV:PGCnp DMG:Wockner_2014 |
|
| 3106 | HLA-B | AS | Bw-47 | Bw-50 | HLAB | SPDA1 | major histocompatibility complex, class I, B | 6p21.3 | CV：GWASDB CV:PGCnp GSMA_I Network PMID:cooccur |
|
| 3107 | HLA-C | D6S204 | HLA-JY3 | HLAC | HLC-C | PSORS1 | major histocompatibility complex, class I, C | 6p21.3 | CV：GWASDB CV:PGCnp DNM:Xu_2012 GSMA_I Network PMID:cooccur |
COMPOSITESET |
| 3108 | HLA-DMA | D6S222E | DMA | HLADM | RING6 | 主要组织相容性复合体II级DM alpha | 6p21.3 | CV:GWAScat CV：GWASDB CV:PGCnp GSMA_I |
|
| 3109 | HLA-DMB | D6S221E | RING7 | 主要的组织相容性复合物，II类，DM Beta | 6p21.3 | CV:GWAScat CV：GWASDB CV:PGCnp DMG:Wockner_2014 GSMA_I PMID:cooccur |
|
| 3111 | HLA-DOA | HLA-DNA | HLA-DZA | HLADZ | 主要组织相容性复合体II级DO alpha | 6p21.3 | CV:PGCnp GSMA_I PMID:cooccur |
|
| 3113 | HLA-DPA1 | DP(W3) | DP(W4) | HLA-DP1A | HLADP | HLASB | PLT1 | 主要组织相容性复合体II级DP alpha 1 | 6p21.3 | CV:PGCnp GSMA_I PMID:cooccur |
|
| 3115 | HLA-DPB1 | DPB1 | HLA-DP | HLA-DP1B | HLA-DPB | 主要组织相容性复合体II级DP beta 1 | 6p21.3 | CV:PGCnp GSMA_I PMID:cooccur |
|
| 3116 | HLA-DPB2 | DP2B | DPB2 | DPbeta2 | HLA-DP2B | 主要组织相容性复合体II级DP beta 2 (pseudogene) | 6p21.3 | CV：GWASDB CV:PGCnp |
|
| 3117 | HLA-DQA1 | CD | CELIAC1 | DQ-A1 | GSE | HLA-DQA | 主要组织相容性复合体II级DQ alpha 1 | 6p21.3 | CV:GWAScat CV：GWASDB CV:PGCnp GSMA_I PMID:cooccur |
|
| 3119 | HLA-DQB1 | CELIAC1 | HLA-DQB | IDDM1 | 主要组织相容性复合体II级DQ beta 1 | 6p21.3 | CV:GWAScat CV：GWASDB CV:PGCnp GSMA_I PMID:cooccur |
|
| 3122 | HLA-DRA | HLA-DRA1 | MLRW | 主要组织相容性复合体II级DR alpha | 6p21.3 | CV：GWASDB CV:PGCnp CV:Ripke_2013 GSMA_I PMID:cooccur |
|
| 3123 | HLA-DRB1 | drb1 |DRW10 |HLA-DR1B |HLA-DRB |SS1 | 主要组织相容性复合体II级DR beta 1 | 6p21.3 | CV:GWAScat CV：GWASDB CV:PGCnp GSMA_I PMID:cooccur |
|
| 3125 | HLA-DRB3 | drb1 |DRW10 |HLA-DR1B |HLA-DR3B | HLA-DRB | SS1 | 主要组织相容性复合体II级DR beta 3 | 6p21.3 | PMID:cooccur | |
| 3127 | HLA-DRB5 | HLA-DRB | 主要组织相容性复合体II级DR beta 5 | 6p21.3 | CV：GWASDB CV:PGCnp CV:Ripke_2013 GSMA_I PMID:cooccur |
|
| 3133 | HLA-E | EA1.2 |EA2.1 |HLA-6.2 |MHC |QA1 | major histocompatibility complex, class I, E | 6p21.3 | CV：GWASDB CV:PGCnp DMG:Jaffe_2016 GSMA_I |
|
| 3134 | HLA-F | CDA12 | HLA-5.4 | HLA-CDA12 | HLAF | major histocompatibility complex, class I, F | 6p21.3 | CV:PGCnp GSMA_I PMID:cooccur |
|
| 3135 | HLA-G | MHC-G | major histocompatibility complex, class I, G | 6p21.3 | CV：GWASDB CV:PGCnp DMG:Jaffe_2016 GSMA_I PMID:cooccur |
|
| 3136 | HLA-H | HLAHP | major histocompatibility complex, class I, H (pseudogene) | 6p21.3 | CV：GWASDB CV:PGCnp |
|
| 717 | C2 | ARMD14 | CO2 | complement component 2 | 6p21.3 | CV：GWASDB CV:PGCnp DMG:Jaffe_2016 GO_Annotation GSMA_I PMID:cooccur |
|
| 7124 | TNF | DIF | TNF-alpha | TNFA | TNFSF2 | TNLG1F | tumor necrosis factor | 6p21.3 | Association CV:PGCnp GO_Annotation gr_cor GR_Ng GR_WM GSMA_I PMID:cooccur |
|
| 3105 | HLA-A | Aw-33 | Aw-74 | HLAA | major histocompatibility complex, class I, A | 6p21.3 | CV:GWAScat CV：GWASDB CV:PGCnp GSMA_I PMID:cooccur |
|
| 3569 | IL6 | BSF-2 | BSF2 | CDF | HGF | HSF | IFN-beta-2 | IFNB2 | IL-6 | interleukin 6 | 7p21 | CV：GWASDB CV:PGCnp PMID:cooccur |
|
| 3574 | IL7 | IL-7 | interleukin 7 | 8q12-q13 | CV：GWASDB CV:PGCnp |
|
| 6363 | CCL19 | CKb11 | ELC | MIP-3b | MIP3B | SCYA19 | C-C基序趋化因子配体19 | 9p13 | CV:PGCnp | |
| 3561 | IL2RG | CD132 | CIDX | IL-2RG | IMD4 | P64 | SCIDX | SCIDX1 | interleukin 2 receptor subunit gamma | Xq13.1 | PMID:cooccur | |